Home / Post.
Post News
Post News
In a challenge to the pharmaceutical industry, Doctors Without Borders has revealed the detailed costs of a study it ran for a tuberculosis treatment regimen.
A New Jersey district judge ruled that the Biden administration’s Medicare drug price negotiation program is constitutional
The pharmaceutical industry saw its image slip last year among patient advocacy groups, according to a new survey.
A tentative settlement has been reached in a long-running shareholder lawsuit that accused health care activist investor Alex Denner of insider trading.
Practice Network, a new initiative, aims to help smaller hospitals implement AI tools in local settings where adoption is currently stymied.
Download STAT’s e-book to explore the challenges and steps to improve care for an aging population.
On May 8, join us for a conversation with practicing neurologists about overcoming current hurdles involved in diagnosing, treating, and monitoring patients in a new…
Amgen said it’s “very encouraged” by interim Phase 2 data for its obesity drug, quickly sparking investor interest. Here are the burning questions surrounding Amgen’s…
A virtual-second model can have long-term benefits across the health care system, from improving patients’ experiences to growing the telehealth market.
A bipartisan Senate bill takes a new approach to persistent drug shortages: have Medicare pay bonuses to hospitals and physicians for contracting that ensures a…